Pinacidil: Difference between revisions
No edit summary |
m Protected "Pinacidil": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)) |
(No difference)
|
Latest revision as of 16:57, 20 August 2015
WikiDoc Resources for Pinacidil |
Articles |
---|
Most recent articles on Pinacidil |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Pinacidil at Clinical Trials.gov Clinical Trials on Pinacidil at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Pinacidil
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Pinacidil Discussion groups on Pinacidil Directions to Hospitals Treating Pinacidil Risk calculators and risk factors for Pinacidil
|
Healthcare Provider Resources |
Causes & Risk Factors for Pinacidil |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Pinacidil is a cyanoguanidine drug that opens ATP-sensitive potassium channels producing peripheral vasodilatation of arterioles.[1] It reduces blood pressure and peripheral resistance and produces fluid retention.[2]
References
- ↑ Gollasch M, Bychkov R, Ried C, Behrendt F, Scholze S, Luft FC, Haller H (1995). "Pinacidil relaxes porcine and human coronary arteries by activating ATP-dependent potassium channels in smooth muscle cells". J. Pharmacol. Exp. Ther. 275 (2): 681–92. PMID 7473155.
- ↑ Reynolds, James Blair; Martindale, William L. (1996). The extra pharmacopoeia (31st ed.). London: Royal Pharmaceutical Society. pp. 2739 pages. ISBN 0-85369-342-0.
External links
- Pinacidil at the US National Library of Medicine Medical Subject Headings (MeSH)